U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C23H23N5O5
Molecular Weight 449.4592
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CH-1504 L-ISOMER

SMILES

NC1=NC(N)=C2C=C(CCC3=CC=C(C=C3)C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=CC2=N1

InChI

InChIKey=NAWXUBYGYWOOIX-SFHVURJKSA-N
InChI=1S/C23H23N5O5/c1-12(21(30)31)10-18(22(32)33)26-20(29)15-7-4-13(5-8-15)2-3-14-6-9-17-16(11-14)19(24)28-23(25)27-17/h4-9,11,18H,1-3,10H2,(H,26,29)(H,30,31)(H,32,33)(H4,24,25,27,28)/t18-/m0/s1

HIDE SMILES / InChI

Molecular Formula C23H23N5O5
Molecular Weight 449.4592
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 17:43:53 UTC 2023
Edited
by admin
on Sat Dec 16 17:43:53 UTC 2023
Record UNII
86T288K8BS
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CH-1504 L-ISOMER
Common Name English
L-MOBILETREX
Common Name English
L-M-TREX
Common Name English
L-GLUTAMIC ACID, N-(4-(2-(2,4-DIAMINO-6-QUINAZOLINYL)ETHYL)BENZOYL)-4-METHYLENE-
Systematic Name English
4-METHYLENE-N-(4-(2-(2,4-DIAMINOQUINAZOLIN-6-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID
Systematic Name English
CH-4051
Code English
L-CH 1504
Code English
(2S)-2-((4-(2-(2,4-DIAMINOQUINAZOLIN-6-YL)ETHYL)BENZOYL)AMINO)-4-METHYLENE-PENTANEDIOIC ACID
Systematic Name English
Code System Code Type Description
PUBCHEM
11532464
Created by admin on Sat Dec 16 17:43:53 UTC 2023 , Edited by admin on Sat Dec 16 17:43:53 UTC 2023
PRIMARY
FDA UNII
86T288K8BS
Created by admin on Sat Dec 16 17:43:53 UTC 2023 , Edited by admin on Sat Dec 16 17:43:53 UTC 2023
PRIMARY
CAS
227016-66-2
Created by admin on Sat Dec 16 17:43:53 UTC 2023 , Edited by admin on Sat Dec 16 17:43:53 UTC 2023
PRIMARY
SMS_ID
300000047882
Created by admin on Sat Dec 16 17:43:53 UTC 2023 , Edited by admin on Sat Dec 16 17:43:53 UTC 2023
PRIMARY
Related Record Type Details
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Alternative Names: CH-4051, L-CH-1504; Originator: University of South Alabama; Developer: Lundbeck A/S; Class: Anti-inflammatory; Mechanism of Action: Tetrahydrofolate dehydrogenase inhibitor; Highest Development Phases: Suspended for Autoimmune disorders, Rheumatoid arthritis; Most Recent Events: 24 Jun 2014 Chelsea Therapeutics has been acquired and merged into Lundbeck A/S, 31 May 2012 Suspended - Phase-I for Autoimmune disorders (in volunteers) in Netherlands (PO), 31 May 2012 Suspended - Phase-II for Rheumatoid arthritis (treatment-resistant) in Czech Republic (PO)